Complete Response of Hepatocellular Carcinoma in a Patient With End-stage Liver Disease treated With Nivolumab: Whishful thinking or Possible?

1Division of Gastroenterology, Department of Internal Medicine, Goethe University Hospital, Frankfurt, Germany 2Liver Center Frankfurt, Goethe University Hospital, Frankfurt, Germany 3University Cancer Center, Goethe University Hospital, Frankfurt, Germany Correspondence: J Trojan, MD, Division of Gastroenterology, Department of Internal Medicine, Goethe University Hospital, Theodor-Stern-Kai 7, Frankfurt 60590, Germany. Email: [email protected] Guarantor of the article: Joerg Trojan, MD. Specific author contributions: Writing of the manuscript, providing all clinical data and images, approval of the manuscript: Joerg Trojan and Christoph Sarrazin. Financial support: None. Potential competing interests: Joerg Trojan and Christoph Sarrazin are serving on the speakers bureaus and act as consultants for Bristol-Myers Squibb.